Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

BACKGROUND: This “Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association Clinical Practice Statement 2022” is intended to provide clinicians an overview of Food and Drug Administration (FDA) approved anti-obesity medications and investigational anti-obesity agents in de...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold E., Fitch, Angela, Christensen, Sandra, Burridge, Karli, Tondt, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662004/
https://www.ncbi.nlm.nih.gov/pubmed/37990711
http://dx.doi.org/10.1016/j.obpill.2022.100018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662004/
https://www.ncbi.nlm.nih.gov/pubmed/37990711
http://dx.doi.org/10.1016/j.obpill.2022.100018

Ejemplares similares